Dynavax Technologies (DVAX)
(Delayed Data from NSDQ)
$11.19 USD
+0.04 (0.36%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $11.20 +0.01 (0.09%) 5:34 PM ET
4-Sell of 5 4
D Value D Growth NA Momentum NA VGM
Fundamental Charts
About Market Cap
As of the previous market close, Dynavax Technologies Corporation has a market cap of $1.34B, which represents its share price of $11.15 multiplied by its outstanding shares number of 120.08M. As a small-cap company, DVAX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
DVAX 11.19 +0.04(0.36%)
Will DVAX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DVAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DVAX
Exelixis (EXEL) Beats Q2 Earnings Estimates
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
DVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates
GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP
Other News for DVAX
Deep Track Capital, LP Increases Stake in Tarsus Pharmaceuticals Inc
Dynavax Technologies Corp (DVAX) Announces Q2 2025 Financial Results Release and Conference ...
Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, ...
Wolverine Asset Management LLC Increases Stake in Future Vision II Acquisition Corp
WOLVERINE ASSET MANAGEMENT LLC Increases Stake in Agriculture & Natural Solutions ...